Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«BCL2

Below is an extended BCL2 patents listing. Click here to return to the gene page.

Patents :

US Patent No.Title
7571055 Systemic lupus erythematosus
7585634 Method of predicting risk of lung cancer recurrence, and a composition, kit and microarray for the same
7585637 Estrogen related receptor, ERR.alpha., a regulator of bone formation
7585947 IL-7 drug substance, composition, preparation and uses
7585964 Methods of analyzing chromosomal translocations using fluorescence in situ hybridization (FISH)
7588767 Microorganisms for therapy
7588771 Microorganisms for therapy
7588903 Use of isogenic drug-resistant cell lines to determine the sequence of chemotherapeutic drug treatment
7589068 Inhibitors of Akt activity
7589070 Surface modification for improving biocompatibility
7589191 siRNA targeting hypoxia-inducible factor 1
7582747 siRNA targeting inner centromere protein antigens (INCENP)
7582746 siRNA targeting complement component 3 (C3)
7572601 Compositions and methods for determining oocyte development potential
7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
7576196 siRNA targeting transducin (beta)-like 3 (TBL3)
7576197 SiRNA targeting KRAS
7576209 Inhibitors of Akt activity
7579355 Inhibitors of Akt activity
7579457 siRNA targeting carbonic anhydrase II
7579458 siRNA targeting synuclein, alpha (SNCA-1)
7582293 Anti-PRO6308 antibodies
7582440 Imaging, diagnosis and treatment of disease
7590493 Methods for determining hepatotoxins
7592138 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy
7592442 siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
7605125 DNA-binding polyamide drug conjugates
7605250 siRNA targeting cAMP-specific phosphodiesterase 4D
7605252 siRNA targeting kinase insert domain receptor (KDR)
7608425 Methods for protein expression in mammalian cells in serum-free medium
7608706 siRNA targeting ras-related nuclear protein
7608707 siRNA targeting survivin
7611839 Methods for diagnosing RCC and other solid tumors
7612046 Method for treating kidney disorders
7612063 Substituted quinobenzoxazine analogs
7612181 Dual variable domain immunoglobulin and uses thereof
7604936 Methods and compositions for diagnosis and monitoring auto immune and chronic inflammatory diseases
7601501 Controlling osteogenesis by inhibition of osteogenic suppressors
7592443 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)
7592444 siRNA targeting myeloid cell leukemia sequence 1
7595158 Bcl2L12 polypeptide activators and inhibitors
7595159 Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
7595387 Modified polynucleotides for reducing off-target effects in RNA interference
7595388 siRNA targeting EPH receptor A3 (EPHA3)
7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B)
7598031 Method for the detection of gene transcripts in blood and uses thereof
7598369 siRNA targeting histamine receptor H1
7598370 siRNA targeting polo-like kinase-1 (PLK-1)
7612196 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.